What is allergy immunotherapy and who uses it?

Allergy immunotherapy is a medical treatment that gradually exposes patients to increasing doses of specific allergens to build tolerance and reduce allergic reactions over time. This treatment, also known as allergy shots or sublingual immunotherapy, works by retraining the immune system to become less sensitive to triggers like pollen, dust mites, pet dander, or insect venom.

According to the American Academy of Allergy, Asthma & Immunology, immunotherapy is primarily used by patients who suffer from severe allergic rhinitis, allergic asthma, or life-threatening insect sting allergies that don't respond adequately to medications or avoidance measures. The treatment involves two phases: a build-up phase where allergen doses are gradually increased over 3-6 months, followed by a maintenance phase lasting 3-5 years with regular injections or sublingual tablets.

Healthcare providers typically recommend immunotherapy for patients who meet specific criteria. Candidates include individuals with confirmed IgE-mediated allergies through skin or blood testing, those whose symptoms significantly impact quality of life despite proper medication use, people who experience severe side effects from allergy medications, and patients who prefer long-term treatment over daily symptom management. Children as young as 5 years old may be candidates, though the decision requires careful evaluation of their ability to communicate adverse reactions.

The treatment is particularly effective for environmental allergens such as tree, grass, and weed pollens, dust mites, mold spores, and animal dander. Immunotherapy can also treat venom allergies from bees, wasps, hornets, and fire ants. However, food allergies are generally not treated with traditional immunotherapy, though specialized oral immunotherapy protocols exist in controlled clinical settings.

Patients with certain conditions are not suitable candidates for immunotherapy. These include individuals with severe asthma that's not well-controlled, those taking beta-blockers or ACE inhibitors due to increased risk of severe reactions, pregnant women beginning treatment, and patients with certain autoimmune conditions or immunodeficiencies.

Success rates vary by allergen type and patient compliance, but studies show 85-90% of patients experience significant symptom improvement. Many patients can reduce or eliminate their need for allergy medications after completing the full course of treatment. The effects often persist for years after discontinuation, making immunotherapy a cost-effective long-term solution compared to lifelong medication use and the related impact of managing seasonal allergies.

Before starting immunotherapy, patients undergo comprehensive allergy testing and medical evaluation. Treatment must be administered in a medical facility equipped to handle allergic reactions, with observation periods required after each injection to monitor for adverse effects.

Related: Allergies & Immune System · When should allergy symptoms be checked by a doctor? · Can allergies cause fatigue and brain fog? · Why are some allergy symptoms worse in the morning?